| # | % | |||||
|---|---|---|---|---|---|---|
| 1 | RETROPHIN INC COM | 3,400,323 | 112,721,000 | 11.33% | ||
| 2 | INSYS THERAPEUTICS INC NEW COM NEW | 2,984,094 | 107,189,000 | 10.77% | ||
| 3 | EAGLE PHARMACEUTICALS INC COM | 1,183,406 | 95,690,000 | 9.61% | ||
| 4 | ABBVIE INC | 1,298,900 | 87,273,000 | 8.77% | ||
| 5 | AKORN INC | 1,843,756 | 80,498,000 | 8.09% | ||
| 6 | UNITED THERAPEUTICS | 387,186 | 67,351,000 | 6.77% | ||
| 7 | ANI PHARMACEUTICALS INC COM | 1,055,791 | 65,512,000 | 6.58% | ||
| 8 | CARDIOVASCULAR SYS INC DEL COM | 2,476,287 | 65,498,000 | 6.58% | ||
| 9 | ORTHOFIX INTERNATIONAL NV | 1,725,697 | 57,155,000 | 5.74% | ||
| 10 | ENANTA PHARMACEUTICALS INC COM | 1,241,321 | 55,847,000 | 5.61% | ||
| 11 | PACIFIC BIOSCIENCES CALIF IN | 5,398,861 | 31,097,000 | 3.12% | ||
| 12 | CLOVIS ONCOLOGY INC | 303,131 | 26,639,000 | 2.68% | ||
| 13 | OSIRIS THERAPEUTICS INC NEW COM | 1,176,195 | 22,889,000 | 2.30% | ||
| 14 | CATALYST PHARMACEUTICALS INC | 5,517,885 | 22,789,000 | 2.29% | ||
| 15 | CELLDEX THERAPEUTICS INC NEW | 751,748 | 18,959,000 | 1.90% | ||
| 16 | EPIRUS BIOPHARMA | 2,265,988 | 12,939,000 | 1.30% | ||
| 17 | DERMA SCIENCES INC COM PAR .01 | 1,760,649 | 12,606,000 | 1.27% | ||
| 18 | HEALTHWAYS INC | 1,010,025 | 12,100,000 | 1.22% | ||
| 19 | ADMA BIOLOGICS, INC. | 1,034,721 | 9,582,000 | 0.96% | ||
| 20 | VERICEL CORP | 2,352,940 | 8,400,000 | 0.84% | ||
| 21 | NANOSTRING TECHNOLOGIES INC | 449,325 | 6,929,000 | 0.70% | ||
| 22 | MERUS LABS INTL INC NEW | 1,641,588 | 3,825,000 | 0.38% | ||
| 23 | SIENTRA INC | 132,135 | 3,334,000 | 0.33% | ||
| 24 | VERACYTE INC | 298,966 | 3,330,000 | 0.33% | ||
| 25 | BIOTIME INC | 655,540 | 2,380,000 | 0.24% | ||
| 26 | IMPRIVATA INC | 95,759 | 1,567,000 | 0.16% | ||
| 27 | BIOLASE INC | 667,664 | 1,162,000 | 0.12% | ||
| 28 | EHEALTH INC COM | 5,242 | 67,000 | 0.01% |
Portfolio data is normalized using SEC Form 13F filings, including the Restatement filing (0001085146-15-001918, filed 2015.08.25).
From 2023-01-03 onward, the SEC requires values to be reported in nearest dollars. Earlier filings reported values in thousands; therefore, positions shown as $0 in older filings may represent actual values between $0–$999.
